Omega Therapeutics Inc (OMGA) Return on Investment ROI from the third quarter of 2024 to third quarter of 2023 and for the year 2024, average high and low, overall ranking from Sep 30 2024 to Sep 30 2023 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Omega Therapeutics Inc   (NASDAQ: OMGA)


Omega Therapeutics Inc's ROI from its third quarter of 2024 to the third quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Omega Therapeutics Inc's ROI in the third quarter of 2024?
Omega Therapeutics Inc recorded a cumulative net loss of $-73 million during 12 months ending in the third quarter of 2024, resulting in a negative return on investment (ROI) of -48.1%.

Within the Healthcare sector 523 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2024 from 3241 to 3718.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter
Y / Y Investment Change TTM -6.29 % 9.34 % 21.08 % 5.97 % -14.65 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 129 143 159 178 191
Return On Investment (TTM) -48.1 % -47.09 % -51.06 % -55.5 % -66.63 %
OMGA's Overall Ranking # 3718 # 3241 # 0 # 0 # 4103
Seq. Investment Change TTM -9.32 % -7.29 % 2.96 % 8.25 % 5.81 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -73 -79 -92 -97 -108

OMGA Company Profile >> Back to OMGA Roi Comparisons >> See Annual OMGA Return On Investment



Return On Investment OMGA's Ranking
Within: No.
Industry # 83
Sector # 524
Overall # 3718

Return On Investment Statistics
High Average Low
-10.44 %
-47.72 %
-72.82 %
(Mar 31 2022)   (Jun 30 2023)



  News about Omega Therapeutics Inc Return on Investment ROI

Omega Therapeutics Appoints Dr. Jennifer Nelson as Senior Vice President of Research, Bolstering Epigenomic Medicine Innovations,

August 14, 2024

Omega Therapeutics Appoints Jennifer Nelson, Ph.D., as Senior Vice President of Research
CAMBRIDGE, Mass., Aug. 14, 2024 – Omega Therapeutics, a leading biotechnology company focused on the development of programmable epigenomic mRNA medicines, announced today the appointment of Jennifer Nelson, Ph.D., as Senior Vice President of Research. Dr. Nelson brings with her over 20 years of experience in the field of RNA- and DNA-based therapies and technologies, along with extensive expertise as a visionary leader in constructing innovative platforms.
Dr. Nelson s appointment comes at a crucial time for Omega Therapeutics as they continue to push the boundaries of epigenomic medicine research. With a proven track record of driving groundbreaking advancements, Dr. Nelson is expected to play a pivotal role in advancing Omega s mission to revolutionize disease treatment through the development of programmable therapies that can precisely target and modify specific genes.





Financial Statements
Omega Therapeutics Inc's III. Quarter Investments $ 129 Millions OMGA's Balance sheet
Omega Therapeutics Inc's III. Quarter Income $ -16 Millions Quarterly OMGA's Income Statement
OMGA's Income by Division See OMGA's Income by Division


OMGA Annual Return On Investment (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021

Total Investments in Millions 178 124 221 0 0
Y / Y Investment Growth 43.15 % -43.96 % - - -
Net Income in Millions -97 -103 -68 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -54.87 % -82.8 % -30.85 % - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
OMGA's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for OMGA's Competitors
Subscribers only: Roi for Omega Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for OMGA's Customers

Other Ratios
OMGA's Roa OMGA's Inventory Turnover Ratio OMGA's Growth Rates OMGA's Dividend Statistics
OMGA's Profitability Ratios OMGA's Asset Turnover Ratio OMGA's Dividend Growth
OMGA's Roe OMGA's Valuation Ratios OMGA's Financial Strength Ratios OMGA's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2024, within Healthcare Sector ROI

Date modified: 2026-09-18T13:11:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.